Wendy Demark-Wahnefried1, Mark A Moyad, Mark M Moyad. 1. School of Nursing and Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA. demar001@mc.duke.edu
Abstract
PURPOSE OF REVIEW: This review integrates recent reports related to the dietary management of prostate cancer with the existing body of science in an effort to best inform practicing clinicians. RECENT FINDINGS: Dietary factors are hypothesized to play a significant role in prostate cancer, and have proven to be important in managing prevalent comorbidities in this patient population (cardiovascular disease, diabetes, and osteoporosis). Data regarding diet and prostate cancer are accumulating and randomized controlled trials are underway which will ultimately yield evidence on which to base recommendations regarding dietary regimens, functional foods, and supplement use. Until that time, most data derive from epidemiologic studies that have limitations in showing cause and effect. During the past year, the greatest and most consistent strides have been made in the area of energy balance, with data consistently showing that overweight and obesity are associated with progressive disease and increased overall mortality. SUMMARY: To date, the strongest evidence regarding diet and prostate cancer relates to energy balance. Urologists aspiring to best clinical practice should encourage their patients to achieve a healthful body weight through regular exercise and a healthful plant-based diet rich in fruits, vegetables, and whole grains. Advocating functional foods or supplements explicitly for cancer control purposes would currently be premature.
PURPOSE OF REVIEW: This review integrates recent reports related to the dietary management of prostate cancer with the existing body of science in an effort to best inform practicing clinicians. RECENT FINDINGS: Dietary factors are hypothesized to play a significant role in prostate cancer, and have proven to be important in managing prevalent comorbidities in this patient population (cardiovascular disease, diabetes, and osteoporosis). Data regarding diet and prostate cancer are accumulating and randomized controlled trials are underway which will ultimately yield evidence on which to base recommendations regarding dietary regimens, functional foods, and supplement use. Until that time, most data derive from epidemiologic studies that have limitations in showing cause and effect. During the past year, the greatest and most consistent strides have been made in the area of energy balance, with data consistently showing that overweight and obesity are associated with progressive disease and increased overall mortality. SUMMARY: To date, the strongest evidence regarding diet and prostate cancer relates to energy balance. Urologists aspiring to best clinical practice should encourage their patients to achieve a healthful body weight through regular exercise and a healthful plant-based diet rich in fruits, vegetables, and whole grains. Advocating functional foods or supplements explicitly for cancer control purposes would currently be premature.
Authors: Scott M Lippman; Phyllis J Goodman; Eric A Klein; Howard L Parnes; Ian M Thompson; Alan R Kristal; Regina M Santella; Jeffrey L Probstfield; Carol M Moinpour; Demetrius Albanes; Philip R Taylor; Lori M Minasian; Ashraful Hoque; Sarah Moody Thomas; John J Crowley; J Michael Gaziano; Janet L Stanford; Elise D Cook; Neil E Fleshner; Michael M Lieber; Philip J Walther; Fadlo R Khuri; Daniel D Karp; Gary G Schwartz; Leslie G Ford; Charles A Coltman Journal: J Natl Cancer Inst Date: 2005-01-19 Impact factor: 13.506
Authors: Stephen J Freedland; Lori J Sokoll; Elizabeth A Platz; Leslie A Mangold; Debra J Bruzek; Phaedre Mohr; Sindy K Yiu; Alan W Partin Journal: J Urol Date: 2005-10 Impact factor: 7.450
Authors: Stephen J Freedland; Kelly A Grubb; Sindy K Yiu; Elizabeth B Humphreys; Matthew E Nielsen; Leslie A Mangold; William B Isaacs; Alan W Partin Journal: J Urol Date: 2005-09 Impact factor: 7.450
Authors: Dean Ornish; Gerdi Weidner; William R Fair; Ruth Marlin; Elaine B Pettengill; Caren J Raisin; Stacey Dunn-Emke; Lila Crutchfield; F Nicholas Jacobs; R James Barnard; William J Aronson; Patricia McCormac; Damien J McKnight; Jordan D Fein; Ann M Dnistrian; Jeanmaire Weinstein; Tung H Ngo; Nancy R Mendell; Peter R Carroll Journal: J Urol Date: 2005-09 Impact factor: 7.450
Authors: Stephen J Freedland; William B Isaacs; Leslie A Mangold; Sindy K Yiu; Kelly A Grubb; Alan W Partin; Jonathan I Epstein; Patrick C Walsh; Elizabeth A Platz Journal: Clin Cancer Res Date: 2005-04-15 Impact factor: 12.531
Authors: James R Hébert; Thomas G Hurley; Brook E Harmon; Sue Heiney; Christine J Hebert; Susan E Steck Journal: Cancer Epidemiol Date: 2011-10-20 Impact factor: 2.984
Authors: Samuel O Antwi; Susan E Steck; Hongmei Zhang; Lareissa Stumm; Jiajia Zhang; Thomas G Hurley; James R Hebert Journal: Cancer Epidemiol Date: 2015-07-09 Impact factor: 2.984
Authors: Joanne L Watters; Mitchell H Gail; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes Journal: Cancer Res Date: 2009-04-21 Impact factor: 12.701
Authors: Kisha I Coa; Katherine Clegg Smith; Ann C Klassen; Laura E Caulfield; Kathy Helzlsouer; Kim Peairs; Lillie Shockney Journal: Support Care Cancer Date: 2014-08-28 Impact factor: 3.603
Authors: Koenraad van Renterghem; Gommert Van Koeveringe; Ruth Achten; Philip van Kerrebroeck Journal: Int Urol Nephrol Date: 2009-06-03 Impact factor: 2.370